ALPN - Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32 revenue of $8.37M misses by $10.31M
- Alpine Immune Sciences press release ( NASDAQ: ALPN ): Q3 GAAP EPS of -$0.42 misses by $0.32 .
- Revenue of $8.37M (-1.8% Y/Y) misses by $10.31M .
- As of September 30, 2022, Alpine’s cash, cash equivalents, restricted cash, and investments totaled $277.1 million.
- Shares +0.27% .
For further details see:
Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32, revenue of $8.37M misses by $10.31M